LOW-VOLUME · SEX-BALANCED
eravacycline Side Effects
eravacycline (also sold as Xerava) is a LOW-VOLUME FAERS extract #516 of 524 by FAERS report count. Still opens on SEX-BALANCED: 35% of sex-coded reports are female (51 F / 95 M).
Data updated 2026-05-15
- 205
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
eravacycline reporting skew - 35% of sex-coded reports are female (51 F / 95 M). Volume band LOW-VOLUME #516 of 524 by FAERS report count; caseload TRACE-CASE.
Thinner FAERS extract for eravacycline (Xerava) (205 reports #516 of 524 by FAERS report count). 35% of sex-coded reports are female (51 F / 95 M). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2019–2025). Stamps TRACE-CASE · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
BLOOD FIBRINOGEN DECREASED leads 16 of 205 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (45 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (33 reports, 16.1%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 13 |
| ACUTE RESPIRATORY DISTRESS SYNDROME | 6 |
| THROMBOCYTOPENIA | 5 |
| BLOOD FIBRINOGEN DECREASED | 4 |
| HYPERTRANSAMINASAEMIA | 4 |
| LACTIC ACIDOSIS | 4 |
| SHOCK | 4 |
| BLASTOMYCOSIS | 3 |
| CONDITION AGGRAVATED | 3 |
| ENTEROCOCCAL INFECTION | 3 |
| MYCOBACTERIUM ABSCESSUS INFECTION | 3 |
| PNEUMONITIS | 3 |
| SEPSIS | 3 |
| SEPTIC SHOCK | 3 |
| DISSEMINATED BLASTOMYCOSIS | 2 |
| PULMONARY BLASTOMYCOSIS | 2 |
| ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED | 1 |
Reactions in Hospitalization Reports
Hospitalization mid-share (57, 27.8%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| BLOOD FIBRINOGEN DECREASED | 9 |
| HYPERTRANSAMINASAEMIA | 8 |
| LACTIC ACIDOSIS | 8 |
| THROMBOCYTOPENIA | 8 |
| ACUTE RESPIRATORY DISTRESS SYNDROME | 6 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 6 |
| BLASTOMYCOSIS | 3 |
| BLOOD BILIRUBIN INCREASED | 3 |
| ENTEROCOCCAL INFECTION | 3 |
| NAUSEA | 3 |
| PNEUMONITIS | 3 |
| PROTHROMBIN TIME PROLONGED | 3 |
| SEPSIS | 3 |
| BILIRUBIN CONJUGATED INCREASED | 2 |
| COAGULOPATHY | 2 |
| CONDITION AGGRAVATED | 2 |
| DIARRHOEA | 2 |
How to read eravacycline FAERS figures (TRACE-CASE · DEATH-HEAVY · HOSP-MID)
FAERS holds 205 voluntary reports linked to eravacycline (Xerava), 2019-2025. Death is listed on 33 (16.1%). Hospitalization appears on 57 (27.8%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with eravacycline
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.
ABS(total_reports) peer at 218 FAERS cases (Δ 13 heavier vs eravacycline); DEATH-MARKED · HOSP-HEAVY · SEX-BALANCED vs this page's TRACE-CASE · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 178 FAERS cases (Δ 27 lighter vs eravacycline); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's TRACE-CASE · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 278 FAERS cases (Δ 73 heavier vs eravacycline); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's TRACE-CASE · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 299 FAERS cases (Δ 94 heavier vs eravacycline); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's TRACE-CASE · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 46.0 pp vs eravacycline's DEATH-HEAVY): CASELOAD · HOSP-MID.
eravacycline stamps DEATH-HEAVY · HOSP-MID; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload TRACE-CASE and the label guide.